150 related articles for article (PubMed ID: 36096838)
1. Cytomegalovirus microRNAs level determination in kidney recipients post transplantation.
Afshari A; Yaghobi R; Golshan M
Virol J; 2022 Sep; 19(1):147. PubMed ID: 36096838
[TBL] [Abstract][Full Text] [Related]
2. Human cytomegalovirus microRNAs are carried by virions and dense bodies and are delivered to target cells.
Mohammad AA; Costa H; Landázuri N; Lui WO; Hultenby K; Rahbar A; Yaiw KC; Söderberg-Nauclér C
J Gen Virol; 2017 May; 98(5):1058-1072. PubMed ID: 28589873
[TBL] [Abstract][Full Text] [Related]
3. Levels of human cytomegalovirus miR-US25-1-5p and miR-UL112-3p in serum extracellular vesicles from infants with HCMV active infection are significantly correlated with liver damage.
Zhang J; Huang Y; Wang Q; Ma Y; Qi Y; Liu Z; Deng J; Ruan Q
Eur J Clin Microbiol Infect Dis; 2020 Mar; 39(3):471-481. PubMed ID: 31749099
[TBL] [Abstract][Full Text] [Related]
4. Different expression pattern of human cytomegalovirus-encoded microRNAs in circulation from virus latency to reactivation.
Zhou W; Wang C; Ding M; Bian Y; Zhong Y; Shen H; Wang J; Zhang CY; Zhang C
J Transl Med; 2020 Dec; 18(1):469. PubMed ID: 33298092
[TBL] [Abstract][Full Text] [Related]
5. An investigation of the utility of plasma Cytomegalovirus (CMV) microRNA detection to predict CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
Talaya A; Giménez E; Pascual MJ; Gago B; Piñana JL; Hernández-Boluda JC; Vázquez L; García M; Serrano D; Hernández M; Albert E; Solano C; Navarro D
Med Microbiol Immunol; 2020 Feb; 209(1):15-21. PubMed ID: 31478067
[TBL] [Abstract][Full Text] [Related]
6. Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA.
Fu M; Gao Y; Zhou Q; Zhang Q; Peng Y; Tian K; Wang J; Zheng X
Gene; 2014 Feb; 536(2):272-8. PubMed ID: 24361963
[TBL] [Abstract][Full Text] [Related]
7. Human Cytomegalovirus-Encoded microRNAs Can Be Found in Saliva Samples from Renal Transplant Recipients.
Waters S; Lee S; Munyard K; Irish A; Price P; Wang BH
Noncoding RNA; 2020 Dec; 6(4):. PubMed ID: 33353107
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of human cytomegalovirus microRNA expression during lytic and quiescent infection.
Shen ZZ; Pan X; Miao LF; Ye HQ; Chavanas S; Davrinche C; McVoy M; Luo MH
PLoS One; 2014; 9(2):e88531. PubMed ID: 24533100
[TBL] [Abstract][Full Text] [Related]
9. Hcmv-miR-UL22A-5p: A Biomarker in Transplantation With Broad Impact on Host Gene Expression and Potential Immunological Implications.
Lisboa LF; Egli A; O'Shea D; Åsberg A; Hartmann A; Rollag H; Pang XL; Tyrrell DL; Kumar D; Humar A
Am J Transplant; 2015 Jul; 15(7):1893-902. PubMed ID: 25833298
[TBL] [Abstract][Full Text] [Related]
10. Human cytomegalovirus microRNA miR-US25-1-5p inhibits viral replication by targeting multiple cellular genes during infection.
Jiang S; Qi Y; He R; Huang Y; Liu Z; Ma Y; Guo X; Shao Y; Sun Z; Ruan Q
Gene; 2015 Oct; 570(1):108-14. PubMed ID: 26055091
[TBL] [Abstract][Full Text] [Related]
11. Human microRNA sequencing and cytomegalovirus infection risk after kidney transplantation.
Fernández-Ruiz M; López-García Á; Valverde-Manso A; Parra P; Rodríguez-Goncer I; Ruiz-Merlo T; López-Medrano F; González E; Polanco N; San Juan R; Andrés A; Aguado JM; Redondo N
Am J Transplant; 2024 Feb; ():. PubMed ID: 38311311
[TBL] [Abstract][Full Text] [Related]
12. Analysis of circulating human and viral microRNAs in patients with congenital cytomegalovirus infection.
Kawano Y; Kawada J; Kamiya Y; Suzuki M; Torii Y; Kimura H; Ito Y
J Perinatol; 2016 Dec; 36(12):1101-1105. PubMed ID: 27684416
[TBL] [Abstract][Full Text] [Related]
13. BK Polyomavirus Micro-RNAs: Time Course and Clinical Relevance in Kidney Transplant Recipients.
Demey B; Descamps V; Presne C; Helle F; Francois C; Duverlie G; Castelain S; Brochot E
Viruses; 2021 Feb; 13(2):. PubMed ID: 33672313
[TBL] [Abstract][Full Text] [Related]
14. Human Cytomegalovirus miR-US33as-5p Targets IFNAR1 to Achieve Immune Evasion During Both Lytic and Latent Infection.
Zhang Q; Song X; Ma P; Lv L; Zhang Y; Deng J; Zhang Y
Front Immunol; 2021; 12():628364. PubMed ID: 33746965
[TBL] [Abstract][Full Text] [Related]
15. Human cytomegalovirus miR-UL36-5p inhibits apoptosis via downregulation of adenine nucleotide translocator 3 in cultured cells.
Guo X; Huang Y; Qi Y; Liu Z; Ma Y; Shao Y; Jiang S; Sun Z; Ruan Q
Arch Virol; 2015 Oct; 160(10):2483-90. PubMed ID: 26212361
[TBL] [Abstract][Full Text] [Related]
16. Detection of circulating hcmv-miR-UL112-3p in patients with glioblastoma, rheumatoid arthritis, diabetes mellitus and healthy controls.
Mohammad AA; Rahbar A; Lui WO; Davoudi B; Catrina A; Stragliotto G; Mellbin L; Hamsten A; Rydén L; Yaiw KC; Söderberg-Nauclér C
PLoS One; 2014; 9(12):e113740. PubMed ID: 25462570
[TBL] [Abstract][Full Text] [Related]
17. Circulating NKG2C + NK cell expressing CD107a/LAMP-1 subsets at the onset of CMV reactivation in seropositive kidney transplant recipients.
Soleimanian S; Yaghobi R; Karimi MH; Geramizadeh B; Roozbeh J; Hossein Aghdaie M; Heidari M
Transpl Immunol; 2021 Dec; 69():101460. PubMed ID: 34492297
[TBL] [Abstract][Full Text] [Related]
18. Human Cytomegalovirus MicroRNAs miR-US5-1 and miR-UL112-3p Block Proinflammatory Cytokine Production in Response to NF-κB-Activating Factors through Direct Downregulation of IKKα and IKKβ.
Hancock MH; Hook LM; Mitchell J; Nelson JA
mBio; 2017 Mar; 8(2):. PubMed ID: 28270578
[TBL] [Abstract][Full Text] [Related]
19. Clinical Utility of QuantiFERON-Cytomegalovirus Test in Management of Kidney Transplant Recipients.
Tarasewicz A; Dębska-Ślizień A; Rutkowski B
Transplant Proc; 2016 Jun; 48(5):1650-3. PubMed ID: 27496465
[TBL] [Abstract][Full Text] [Related]
20. Human Cytomegalovirus UL7, miR-US5-1, and miR-UL112-3p Inactivation of FOXO3a Protects CD34
Hancock MH; Crawford LB; Perez W; Struthers HM; Mitchell J; Caposio P
mSphere; 2021 Jan; 6(1):. PubMed ID: 33408225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
